144 related articles for article (PubMed ID: 18320071)
1. Pharmacological inhibition of DNA methylation induces proinvasive and prometastatic genes in vitro and in vivo.
Ateeq B; Unterberger A; Szyf M; Rabbani SA
Neoplasia; 2008 Mar; 10(3):266-78. PubMed ID: 18320071
[TBL] [Abstract][Full Text] [Related]
2. Identification of hypermethylation in hepatocyte cell adhesion molecule gene promoter region in bladder carcinoma.
Tao J; Liu Q; Wu X; Xu X; Zhang Y; Wang Q; Luo C
Int J Med Sci; 2013; 10(13):1860-7. PubMed ID: 24324362
[TBL] [Abstract][Full Text] [Related]
3. Demethylation of the miR-146a promoter by 5-Aza-2'-deoxycytidine correlates with delayed progression of castration-resistant prostate cancer.
Wang X; Gao H; Ren L; Gu J; Zhang Y; Zhang Y
BMC Cancer; 2014 May; 14():308. PubMed ID: 24885368
[TBL] [Abstract][Full Text] [Related]
4. DNA methyltransferase inhibitor 5-aza-CdR enhances the radiosensitivity of gastric cancer cells.
Qiu H; Yashiro M; Shinto O; Matsuzaki T; Hirakawa K
Cancer Sci; 2009 Jan; 100(1):181-8. PubMed ID: 19037991
[TBL] [Abstract][Full Text] [Related]
5. Synergic antiproliferative effect of DNA methyltransferase inhibitor in combination with anticancer drugs in gastric carcinoma.
Zhang X; Yashiro M; Ohira M; Ren J; Hirakawa K
Cancer Sci; 2006 Sep; 97(9):938-44. PubMed ID: 16805821
[TBL] [Abstract][Full Text] [Related]
6. Chemical genomic screening for methylation-silenced genes in gastric cancer cell lines using 5-aza-2'-deoxycytidine treatment and oligonucleotide microarray.
Yamashita S; Tsujino Y; Moriguchi K; Tatematsu M; Ushijima T
Cancer Sci; 2006 Jan; 97(1):64-71. PubMed ID: 16367923
[TBL] [Abstract][Full Text] [Related]
7. Trans-regulated silencing and reactivation of TP53 tumor suppressor gene in malignant transformation and its reversion.
Yang L; Sasaki MS
Jpn J Cancer Res; 2000 Nov; 91(11):1111-8. PubMed ID: 11092975
[TBL] [Abstract][Full Text] [Related]
8. 5-aza-2'-deoxycytidine activates iron uptake and heme biosynthesis by increasing c-Myc nuclear localization and binding to the E-boxes of transferrin receptor 1 (TfR1) and ferrochelatase (Fech) genes.
Ning B; Liu G; Liu Y; Su X; Anderson GJ; Zheng X; Chang Y; Guo M; Liu Y; Zhao Y; Nie G
J Biol Chem; 2011 Oct; 286(43):37196-206. PubMed ID: 21903580
[TBL] [Abstract][Full Text] [Related]
9. The Levels of H11/HspB8 DNA methylation in human melanoma tissues and xenografts are a critical molecular marker for 5-Aza-2'-deoxycytidine therapy.
Smith CC; Li B; Liu J; Lee KS; Aurelian L
Cancer Invest; 2011 Jul; 29(6):383-95. PubMed ID: 21649464
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic remodelling of gene expression profiles of neoplastic and normal tissues: immunotherapeutic implications.
Coral S; Covre A; Nicolay HJ; Parisi G; Rizzo A; Colizzi F; Dalla Santa S; Fonsatti E; Fratta E; Sigalotti L; Maio M
Br J Cancer; 2012 Sep; 107(7):1116-24. PubMed ID: 22910318
[TBL] [Abstract][Full Text] [Related]
11. Treatment with a DNA methyltransferase inhibitor feminizes zebrafish and induces long-term expression changes in the gonads.
Ribas L; Vanezis K; Imués MA; Piferrer F
Epigenetics Chromatin; 2017 Dec; 10(1):59. PubMed ID: 29216900
[TBL] [Abstract][Full Text] [Related]
12. Symmetric dimeric bisbenzimidazoles DBP(n) reduce methylation of RARB and PTEN while significantly increase methylation of rRNA genes in MCF-7 cancer cells.
Kostyuk SV; Kvasha MA; Khrabrova DA; Kirsanova OV; Ershova ES; Malinovskaya EM; Veiko NN; Ivanov AA; Koval VS; Zhuze AL; Tashlitsky VH; Umriukhin PE; Kutsev SI; Gromova ES
PLoS One; 2018; 13(1):e0189826. PubMed ID: 29329300
[TBL] [Abstract][Full Text] [Related]
13. Promoter hypermethylation as a novel regulator of ANO1 expression and function in prostate cancer bone metastasis.
Shin Y; Kim S; An W
Sci Rep; 2024 May; 14(1):11595. PubMed ID: 38773164
[TBL] [Abstract][Full Text] [Related]
14. Methyl-CpG binding domain protein 2 (Mbd2) drives breast cancer progression through the modulation of epithelial-to-mesenchymal transition.
Mahmood N; Arakelian A; Szyf M; Rabbani SA
Exp Mol Med; 2024 Apr; 56(4):959-974. PubMed ID: 38556549
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in understanding DNA methylation of prostate cancer.
Shin HJ; Hua JT; Li H
Front Oncol; 2023; 13():1182727. PubMed ID: 37234978
[TBL] [Abstract][Full Text] [Related]
16. Consistent DNA Hypomethylations in Prostate Cancer.
Araúzo-Bravo MJ; Erichsen L; Ott P; Beermann A; Sheikh J; Gerovska D; Thimm C; Bendhack ML; Santourlidis S
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613831
[TBL] [Abstract][Full Text] [Related]
17. Decitabine Treatment Induces a Viral Mimicry Response in Cervical Cancer Cells and Further Sensitizes Cells to Chemotherapy.
Alexandraki A; Strati K
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430521
[TBL] [Abstract][Full Text] [Related]
18. 5-methylcytosine turnover: Mechanisms and therapeutic implications in cancer.
Turpin M; Salbert G
Front Mol Biosci; 2022; 9():976862. PubMed ID: 36060265
[TBL] [Abstract][Full Text] [Related]
19. Misregulation of the expression and activity of DNA methyltransferases in cancer.
Mensah IK; Norvil AB; AlAbdi L; McGovern S; Petell CJ; He M; Gowher H
NAR Cancer; 2021 Dec; 3(4):zcab045. PubMed ID: 34870206
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
